Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The iris after prostanoid treatment.

I Grierson1, K P Cracknell, N Pfeiffer

  • 1Unit of Ophthalmology, Department of Medicine, University of Liverpool, Liverpool, England. eye123@liv.ac.uk

Current Opinion in Ophthalmology
|February 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal corneal thickness changes and their relation to ocular and systemic cardiovascular risk factors: Results from the Gutenberg Health Study.

Acta ophthalmologica·2026
Same author

Associations of preterm birth and neonatal stress exposure with chronic pain in adulthood - Results from the Gutenberg prematurity study.

Journal of psychosomatic research·2024
Same author

The association of depression and all-cause mortality: Explanatory factors and the influence of gender.

Journal of affective disorders·2022
Same author

Frequency of cataract surgery and its impact on visual function-results from the German Gutenberg Health Study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2020
Same author

[Pulsatile tumor of the orbit].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020
Same author

Recurrence of paraproteinemic keratopathy after penetrating keratoplasty and its assessment with confocal microscopy.

American journal of ophthalmology case reports·2018
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Prostanoid eye drops can cause iris color change, likely due to increased melanin production, not harmful cell growth. This darkening appears safe, without significant inflammation or glaucoma risk.

Area of Science:

  • Ophthalmology
  • Cell Biology

Background:

  • Prostanoid medications are used to treat glaucoma.
  • Iris color change is a known side effect of some prostanoids.

Purpose of the Study:

  • To investigate the morphologic changes in the iris associated with prostanoid-induced color change.
  • To determine the underlying mechanism and potential risks of this side effect.

Main Methods:

  • Morphologic examination of iris tissue.
  • Histological analysis to assess cellular changes.

Main Results:

  • Prostanoid-induced iris color change is not linked to significant pathology.
  • No evidence of melanocyte proliferation was observed.
  • Increased melanogenesis is the probable cause of iris darkening.

Related Experiment Videos

  • Anterior border zone thickening may occur but is likely due to pigmentation.

    • Conclusions:

    • Prostanoid-induced iris color change is a benign phenomenon.
    • The mechanism involves increased melanin production, not harmful cellular activity.
    • Further research is needed to confirm the nature of anterior border zone changes.